Skip to main content
. 2020 Jan 1;11(4):906–918. doi: 10.7150/jca.33766

Table 1.

Correlation analysis of immunohistochemical expression of p53, p21, nm23 and VEGF with clinicopathological data.

p53 p21 nm23 VEGF
Variables Number Negative Positive χ2 p Negative Positive χ2 p Negative Positive χ2 p Negative Positive χ2 p
Gender
Male 377 149 228 0.230 0.631 274 103 0.670 0.413 40 337 0.493 0.482 85 292 2.437 0.119
Female 42 15 27 33 9 3 39 14 28
Age
≤46 229 83 146 1.778 0.182 157 72 5.722 0.017 20 209 1.282 0.258 57 172 0.447 0.504
>46 190 81 109 150 40 23 167 42 148
Race
Han 261 113 148 5.014 0.025 189 72 0.259 0.611 32 229 3.000 0.083 62 199 0.006 0.937
Minority 158 51 107 118 40 11 147 37 121
Smoking status
No 270 109 161 0.482 0.488 195 75 0.425 0.514 29 241 0.189 0.664 72 198 3.886 0.049
Yes 149 55 94 112 37 14 135 27 122
Drinking status
No 250 101 149 0.413 0.521 180 70 0.510 0.475 27 223 0.194 0.659 60 190 0.048 0.827
Yes 169 63 106 127 42 16 153 39 130
BMI
≤25 348 135 213 0.104 0.747 249 99 3.095 0.079 38 310 0.963 0.327 78 270 1.677 0.195
>25 71 29 42 58 13 5 66 21 50
AFP(ng/ml) a
≤400 214 92 122 2.302 0.129 164 50 2.007 0.157 23 191 0.275 0.600 55 159 0.841 0.359
>400 175 62 113 123 52 16 159 38 137
Child pugh b
A 337 127 209 1.503 0.220 248 88 0.425 0.514 31 305 1.371 0.242 77 259 0.848 0.357
B 56 26 30 39 17 8 48 16 40
BCLC stage
A 239 93 145 0.136 0.934 174 64 0.693 0.707 30 208 3.464 0.177 55 183 1.170 0.557
B 69 28 41 53 16 4 65 14 55
C 111 42 69 79 32 9 102 30 81
No. of tumors
Single (n=1) 308 119 189 0.124 0.725 227 81 0.111 0.739 36 272 2.566 0.109 76 232 0.707 0.400
Multiple (n>1) 111 45 66 80 31 7 104 23 88
Tumor size
≤5cm 138 58 80 0.721 0.396 110 28 4.358 0.037 17 121 0.945 0.331 31 107 0.154 0.694
>5cm 281 106 175 197 84 26 255 68 213
Cirrhosis
No 50 15 34 1.640 0.200 27 22 9.576 0.002 7 42 0.962 0.327 9 40 0.868 0.351
Yes 369 148 221 280 89 36 333 90 279
Pathological grade c
Well 24 14 10 3.787 0.052 22 2 4.306 0.038 3 21 0.196 0.658 7 17 0.437 0.509
Moderately/Poorly 340 130 210 246 94 33 307 79 261
PVTT
No 352 141 211 1.500 0.827 258 94 0.070 0.999 37 315 2.087 0.720 79 273 5.325 0.256
Yes 67 3 8 8 3 1 10 1 10
Radical resectiond
No 169 89 149 0.491 0.484 172 66 0.420 0.517 24 214 0.034 0.853 63 175 2.644 0.104
Yes 238 69 100 127 42 18 151 33 136
Antiviral therapy
No 276 103 173 1.127 0.288 187 89 12.564 <0.001 36 240 6.791 0.009 65 211 0.003 0.959
Yes 143 61 82 120 23 7 136 34 109

a information regarding AFP level was unavailable for 30 patients; b information regarding child-pugh was unavailable for 26 patients; c information regarding pathological grade was unavailable for 55 patients; d: information regarding radical resection was unavailable for 12 patients. HBV, hepatitis B virus; HCC, hepatocellular carcinoma; BMI, body mass index; AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; PVTT, portal vein tumor thrombus.